Penciclovir News

← Back to News Overview


Penciclovir currently has 0 news articles, with 9 predicted indications.

This page combines the AI-predicted indications for Penciclovir with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
  • Evidence level: L5
  • Predicted indications (9):
    • Cysticercosis | 98.99% | No credible mechanism (cestode lacks viral TK) (99.0%)
    • Coenurosis | 98.75% | No known antiparasitic target (99.0%)
    • Intestinal helminthiasis | 98.70% | No anthelmintic activity (99.0%)
    • Malignant pleural mesothelioma | 98.51% | Only a speculative viral TK suicide-gene concept (explored with ganciclovir, not penciclovir) (99.0%)
    • Endomyometritis | 98.45% | No antibacterial activity (99.0%)
    • Malignant epithelioid mesothelioma | 98.40% | Same speculative link as above (99.0%)
    • Sarcomatoid mesothelioma | 98.26% | No intrinsic antitumour mechanism (99.0%)
    • Synovium cancer | 98.09% | No identified mechanism (99.0%)
    • Malignant visceral pleura tumour | 98.03% | Same speculative link as mesothelioma (99.0%)

View full drug report →

No related news yet. When news mentions this drug, it will be collected and shown here automatically.

Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.

Copyright © 2026 藥提醒科技有限公司 (yao.care). This report is for research purposes only and does not constitute medical advice.

This site uses Just the Docs, a documentation theme for Jekyll.